3 Dividend Aristocrats to Own For a Lifetime Of Passive Income
Briefly

3 Dividend Aristocrats to Own For a Lifetime Of Passive Income
Dividend checks arrive on schedules set by corporate boards, offering predictability that contrasts with stopped paychecks, cut bonuses, and unexpected layoffs. Income investors value cash flow that does not depend on showing up to work. Dividend Aristocrats provide growing payouts through recessions, pandemics, and rate cycles, using decades of uninterrupted annual increases rather than fixed coupons. A screened set of dividend equity stocks targets massive dividends, aiming for over $750 in passive annual income by investing $10,000 in each stock. Johnson & Johnson offers durable healthcare demand, strong free cash flow, and a raised quarterly dividend. Coca-Cola provides an asset-light concentrate model and steady dividend support.
"Paychecks stop. Bonuses get cut. Layoff announcements arrive without warning. Dividend checks, by contrast, keep landing in brokerage accounts on a schedule set years in advance by boards that treat the payout like a contract with shareholders. For income investors, that predictability is the whole point."
"Dividend Aristocrats, companies with decades of uninterrupted annual increases, answer that bar with growing payouts rather than fixed coupons, plus the liquidity and optionality that rental properties and private credit funds simply cannot match. We screened our 24/7 Wall St. dividend equity research database, looking for stocks that pay massive dividends, and we found a collection of companies that, combined, can generate over $750 a year in passive annual income if you invest just $10,000 in each stock at the time of this writing."
"Johnson & Johnson runs a diversified healthcare franchise split between Innovative Medicine and MedTech, with $96.4 billion in trailing revenue and one of only two AAA corporate credit ratings in the United States. Shares closed at $228.92 on May 18, 2026, up 55.46% over the past year. The income case rests on a structural advantage: durable healthcare demand. U.S. healthcare spending reached $3,741.3 billion in March 2026, up $277.7 billion year over year, funding the kind of free cash flow that supports 64 consecutive years of dividend increases. The board just raised the quarterly payout to $1.34 per share, a 3.1% increase."
Read at 24/7 Wall St.
Unable to calculate read time
[
|
]